Target intelligence / Profile preview

RNA-binding motif protein 8A (RBM8A)

Target
RBM8A
Molecular classification
RNA-binding protein, Exon junction complex core component, Ribonucleoprotein, Other
01

Overview

RNA-binding motif protein 8A (RBM8A) is a conserved RNA-binding protein predominantly found in the nucleus, functioning as a core component of the exon junction complex (EJC). RBM8A is crucial in post-transcriptional mRNA processing, including mRNA splicing, transport, surveillance (notably nonsense-mediated decay), and regulation of stability/mRNA degradation. It helps carry mRNA from the nucleus to the cytoplasm and associates with spliced mRNAs to mark exon junctions, thereby facilitating correct gene expression. Loss-of-function mutations or deletions in RBM8A lead to thrombocytopenia-absent radius syndrome (TAR), a rare congenital disorder, and abnormal RBM8A expression is linked to several cancers and neurodevelopmental conditions[1][4][7][9][13]. No drugs directly target RBM8A, and inhibition is not compatible with life, underscoring its essential cellular function.

Other names
RNA-binding protein 8ARBM8HSPC114MDS014BOV-1ZNRPBOV-1ABOV-1BBOV-1CY14Binder of OVCA1-1Binder of OVCA1Exon junction complex core component Y14C1DELq21.1DEL1q21.1RBM8BTARZRNP1
02

Biological functions

mRNA transport from nucleus to cytoplasmRegulation of mRNA splicing and processingmRNA surveillance (including nonsense-mediated decay)Control of mRNA stability and degradationCell cycle regulationApoptosis regulation
03

Disease associations

Thrombocytopenia-absent radius (TAR) syndromeCancer (e.g., cervical cancer, lung cancer, myeloma)Neurodevelopmental disordersAlzheimer’s disease (association)1q21.1 deletion syndrome1q21.1 duplication syndrome
04

Safety considerations

Complete loss of RBM8A protein is incompatible with life, indicating high safety risk for any therapeutic strategy fully inhibiting RBM8A functionGenetic deletions/mutations result in severe developmental disease
05

Biomarkers

Reduced RBM8A expression for TAR syndrome diagnosisOverexpression in malignant tumorsPotentially, RBM8A mRNA/protein levels for disease states and development

Beyond the preview

Go deeper on RNA-binding motif protein 8A (RBM8A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA-binding motif protein 8A (RBM8A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call